Area of research
Neurology · Cancer Research
Research interest
Research interests include Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Cancer therapeutics and mechanisms, and Adrenal and Paraganglionic Tumors.
A phase 2 randomized study of chemoimmunotherapy with or without eflornithine (DFMO) in relapsed/refractory neuroblastoma: A Children’s Oncology Group (COG) report.
Long‐Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children’s Oncology Group
Prospective Evaluation of Radiation Dose Escalation in Patients With High-Risk Neuroblastoma and Gross Residual Disease After Surgery: A Report From the Children’s Oncology Group ANBL0532 Study
Collaborative Research: Correlated Phases in an Unusual Family of Crystalline 2D Materials
Collaborative Research: DMREF: Developing and Harnessing the Platform of Quasi-One-Dimensional Topological Materials for Novel Functionalities and Devices
I-Corps: Development of decentralized anomaly detection for industrial facilities
Collaborative Research: High-dimensional quantum states in two-dimensional material quantum dots
CAREER: Realization, Manipulation, and Interaction of Majorana Kramers Pairs
DMREF Collaborative Research: Establishing the Platform of Quasi-one-dimensional Topological Insulators with Emergent Functionalities